News

News and Press Releases
Research | About the CF Foundation | Our Research Approach Cystic Fibrosis Foundation Announces Nine Research Agreements to Advance Its Path to a Cure

The Cystic Fibrosis Foundation announced a new set of research agreements to drive progress on its Path to a Cure. The nine awards will advance a variety of tools and strategies to accelerate treatments for the underlying cause of cystic fibrosis for all people with CF, regardless of their mutations.

| 4 min read
About the CF Foundation | Our Research Approach CF Foundation Awards $2.76 Million for 11 COVID-19 Studies

Today, the Cystic Fibrosis Foundation awarded $2.76 million for 11 laboratory studies that will advance our understanding of the underlying factors that impact COVID-19 outcomes in people with cystic fibrosis. Ultimately, insights gained from this body of research may be used to improve future treatments.

| 5 min read
Our Research Approach | About the CF Foundation CF Foundation Awards up to $3.75M to Matinas BioPharma to Develop Oral Version of Antibiotic for NTM Infections

Potential oral formulation of drug targeting nontuberculous mycobacteria infections could reduce side effects of current treatment 

| 3 min read
Research | About the CF Foundation | Our Research Approach CF Foundation Awards up to $2.4M for a New Approach to Reduce Infections

Potential treatment from Calithera Biosciences minimizes growth of germs in the lungs

| 3 min read
Research | About the CF Foundation | Our Research Approach CF Foundation Awards Nearly $15 Million to Spur Infection Research

Thirty-three new projects are being funded as part of the Foundation's $100 million Infection Research Initiative.

| 4 min read
Our Research Approach CF Foundation Leadership Represents the CF Community Voice During Global Antibiotics Initiative Launch

On July 9, the Cystic Fibrosis Foundation's President and CEO, Dr. Michael P. Boyle, participated in the global launch of the AMR Action Fund. Alongside leaders in global health, Dr. Boyle highlighted the critical need of antibiotics for people living with CF and stressed that research investment alone will not solve the challenges of antibiotic development.

| 3 min read
Research | Antibiotics | Our Research Approach CF Foundation Awards Up to $5.6 Million to Develop Novel Antibiotic to Fight Drug-Resistant Bacteria

The Cystic Fibrosis Foundation has awarded up to $5.6 million to Microbion Corporation to develop a novel, inhaled antibiotic to treat drug-resistant bacterial infections in people with cystic fibrosis.

| 2 min read
Research | About the CF Foundation | Clinical Trials | Our Research Approach CF Foundation Announces up to $5M Award to Support First-Ever Controlled Clinical Study of Phage Therapy in Cystic Fibrosis

Study reaffirms the Foundation's commitment to advance solutions to the growing challenge of antibiotic resistance and evaluate the use of phage to treat infections for people with CF

| 4 min read
Research | Clinical Trials | Our Research Approach CF Foundation Awards Funding for First-Ever Controlled Clinical Study of Phage Therapy in CF

The Cystic Fibrosis Foundation awarded up to $5 million to Armata Pharmaceuticals for the first-ever controlled clinical study of phage therapy in CF, reaffirming the Foundation's commitment to advance innovative solutions to the growing challenge of antibiotic resistance.

| 3 min read